Munich - Delayed Quote EUR
Cresco Labs Inc (6CQ.MU)
0.5640
-0.0030
(-0.53%)
As of 8:01:09 AM GMT+2. Market Open.
Loading Chart for 6CQ.MU
- Previous Close
0.5670 - Open
0.5640 - Bid 0.5125 x --
- Ask 0.5410 x --
- Day's Range
0.5640 - 0.5640 - 52 Week Range
0.5035 - 1.7960 - Volume
0 - Avg. Volume
230 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 6CQ.MU
View MorePerformance Overview: 6CQ.MU
Trailing total returns as of 6/2/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
6CQ.MU
31.64%
S&P/TSX Composite index (^GSPTSE)
7.00%
1-Year Return
6CQ.MU
66.43%
S&P/TSX Composite index (^GSPTSE)
18.30%
3-Year Return
6CQ.MU
83.88%
S&P/TSX Composite index (^GSPTSE)
25.26%
5-Year Return
6CQ.MU
87.12%
S&P/TSX Composite index (^GSPTSE)
71.12%
Compare To: 6CQ.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
1.1600
-4.13%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.6640
+2.87%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.7210
-1.99%
Mkt Cap EUR 663.306M
Industry Drug Manufacturers—Specialty & Generic
4.7320
+2.74%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.2000
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.6540
+3.38%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0430
+8.04%
Mkt Cap EUR 21.415M
Industry Drug Manufacturers—Specialty & Generic
1.1980
-1.64%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.1810
-2.16%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.5440
-1.01%
Mkt Cap EUR 659.893M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 6CQ.MU
View MoreValuation Measures
As of 5/30/2025
Market Cap
186.41M
Enterprise Value
617.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.32
Price/Book (mrq)
0.49
Enterprise Value/Revenue
1.00
Enterprise Value/EBITDA
7.34
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--